EV/EBITDA
-7.21
+0.24+3.22%
Wed, 12 Mar 2025 23:26:15 GMT
Summary
- As of March 13, 2025, CADL EV/EBITDA is -7.21, with a rise of +0.24 (+3.22%) during the most recent trading day.
- CADL EV/EBITDA is now -2102.78% below its all-time high of 0.36.
Performance
CADL EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CADL EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | +3.2% | -3.2% | -3.2% |
1 m1 month | +8.8% | -8.9% | -8.8% |
3 m3 months | -53.4% | +53.3% | +11.8% |
6 m6 months | -61.7% | +69.9% | +21.1% |
ytdytd | +9.1% | -9.1% | -9.1% |
1 y1 year | - | +734.3% | +392.6% |
5 y5 years | - | - | - |
CADL EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -0.4% | -11.14 | +35.3% | |
3 m | 3-month | -4.46 | -61.7% | -11.14 | +35.3% |
6 m | 6-month | -2.62 | -175.2% | -11.14 | +35.3% |
1 y | 1-year | -1.33 | -442.1% | -12.79 | +43.6% |
3 y | 3-year | 0.36 | -2102.8% | -12.79 | +43.6% |
5 y | 5-year | 0.36 | -2102.8% | -16.88 | +57.3% |
alltime | all time | 0.36 | -2102.8% | -16.88 | +57.3% |
Candel Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | -7.21(-9.1%) |
2024 | -7.93(+844.0%) |
Date | Value |
---|---|
2023 | -0.84(+546.2%) |
2022 | -0.13(-97.8%) |
2021 | -5.83 |
FAQ
- What is Candel Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Candel Therapeutics?
- What is CADL EV/EBITDA year-to-date change?
What is Candel Therapeutics EV/EBITDA?
The current EV/EBITDA of CADL is -7.21
What is the all time high EV/EBITDA for Candel Therapeutics?
Candel Therapeutics all-time high EV/EBITDA is 0.36
What is CADL EV/EBITDA year-to-date change?
Candel Therapeutics EV/EBITDA has changed by +0.72 (+9.08%) since the beginning of the year